QUOTE
Dr. Reddys Laboratories Ltd (RDY)
33.89
 $0.68 (2.05%) Jan 26
|
+1-212-2706000
http://www.drreddys.com |
|
|
| PRICES |
| Open |
Volume |
| 33.53 |
374,500 |
| High |
Low |
| 34.24 |
33.38 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 5722 |
412,800 |
| 52wk High |
52wk Low |
| 39.24 |
29.07 |
|
| RATIOS |
| P/E |
EPS |
| 22.59 |
1.50 |
| BV |
P/BV |
| 254.16 |
0.13 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| 0.25 |
0.74% |
| Shares |
Inst Owner |
| 168.85 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of INR)
|
| |
2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$65,095.09 | $50,005.63 | $69,441 | $70,277 |
| Operating Income |
$11,331.45 | $3,357.70 | $-2,834 | $2,008 |
| Net Income |
$9,326.84 | $3,846 | $-5,168 | $1,068 |
| Balance Sheet |
| Total Assets |
- | - | $83,792 | $80,330 |
| Total Equity |
- | - | $42,045 | $42,915 |
| Total Liabilities |
- | - | $41,747 | $37,415 |
| Cash Flow |
| Operating |
- | - | $4,505 | $13,226 |
| Investing |
- | - | $-3,472 | $-6,998 |
| Financing |
- | - | $-2,527 | $-5,307 |
| Net Cash Change |
- | - | $-1,608 | $1,167 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
20 January 2010
06 May 2010
22 July 2010
29 October 2010
|
20 January 2009
18 May 2009
23 October 2009
|
|
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
K. Anji Reddy |
Chairman of the Board | |
|
Arun Sawhney |
President - API |
|
R. Rajagopalan |
President - Discovery Research |
|
Abhijeet Mukherjee |
President - Developing Businesses |
|
Rajinder Kumar |
President - Research, Development and Commercialization |
|
Mark R. Hartman |
President – North America Generics |
|
Jaspal S. Bajwa |
President - Branded Formulations (Rest of the World) Business |
|
Saumen Chakraborty |
Chief Financial Officer; President - IT and BPE |
|
V. S. Vasudevan |
President - Europe Generics |
|
G. V. Prasad |
Vice Chairman of the Board, Chief Executive Officer |
|
|
|
